Alkermes Inc. plc
Symbol: ALKS (NASDAQ)
29.05
▲ (2.80%) 0.790
Company Description:
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Key Stats
- Today's Open: $28.49
- Today's High: $29.12
- Today's Low: $28.195
- Today's Volume: 1.59M
- Yesterday Close: $28.26
- Yesterday High: $28.61
- Yesterday Low: $28.165
- Yesterday Volume: 1.01M
- Last Min Volume: 1
- Last Min High: $29.05
- Last Min Low: $29.05
- Last Min VWAP: $29.05
Company Profile
- Name: Alkermes Inc. plc
- Website: https://www.alkermes.com
- Listed Date: 1991-07-16
- Location: DUBLIN 4, L2
- Market Status: Active
- CIK Number: 0001520262
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.67B
- Round Lot: 100
- Outstanding Shares: 165.08M
- Asset Type: CS
RECENT FILINGS FOR ALKS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-04 | 4 | View |
| 2025-07-29 | S-8 | View |
| 2025-07-29 | 10-Q | View |
| 2025-07-29 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 4 | View |
| 2025-06-10 | 144 | View |
| 2025-06-09 | 144 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
Latest News on ALKS